Kidney stone natural history, complications and prognosis: Difference between revisions
| Line 28: | Line 28: | ||
**[[Chronic renal failure]] | **[[Chronic renal failure]] | ||
**[[Hypertension]]<ref name="pmid9820450">{{cite journal |vauthors=Madore F, Stampfer MJ, Willett WC, Speizer FE, Curhan GC |title=Nephrolithiasis and risk of hypertension in women |journal=Am. J. Kidney Dis. |volume=32 |issue=5 |pages=802–7 |date=November 1998 |pmid=9820450 |doi= |url=}}</ref> | **[[Hypertension]]<ref name="pmid9820450">{{cite journal |vauthors=Madore F, Stampfer MJ, Willett WC, Speizer FE, Curhan GC |title=Nephrolithiasis and risk of hypertension in women |journal=Am. J. Kidney Dis. |volume=32 |issue=5 |pages=802–7 |date=November 1998 |pmid=9820450 |doi= |url=}}</ref> | ||
**[[Cardiovascular Disease]]<ref name="pmid23917291">{{cite journal |vauthors=Ferraro PM, Taylor EN, Eisner BH, Gambaro G, Rimm EB, Mukamal KJ, Curhan GC |title=History of kidney stones and the risk of coronary heart disease |journal=JAMA |volume=310 |issue=4 |pages=408–15 |date=July 2013 |pmid=23917291 |pmc=4019927 |doi=10.1001/jama.2013.8780 |url=}}</ref> | |||
**[ | |||
===Prognosis=== | ===Prognosis=== | ||
Revision as of 00:33, 22 June 2018
|
Kidney stone Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Kidney stone natural history, complications and prognosis On the Web |
|
American Roentgen Ray Society Images of Kidney stone natural history, complications and prognosis |
|
FDA on Kidney stone natural history, complications and prognosis |
|
CDC on Kidney stone natural history, complications and prognosis |
|
Kidney stone natural history, complications and prognosis in the news |
|
Blogs onKidney stone natural history, complications and prognosis |
|
Risk calculators and risk factors for Kidney stone natural history, complications and prognosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
If left untreated, [#]% of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].
OR
Common complications of [disease name] include [complication 1], [complication 2], and [complication 3].
OR
Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [#]%.
Natural History, Complications, and Prognosis
Natural History
- The symptoms of (disease name) usually develop in the first/ second/ third decade of life, and start with symptoms such as ___.
- The symptoms of (disease name) typically develop ___ years after exposure to ___.
- If left untreated, <30% of patients with nephrolithiasis may progress to develop renal colicky pain due to increase in rate of growth.[1]
- Most of the stones pass spontaneously. about 10-20% of symptom causing stones fail to pass.[2]
- Less than 30% caused renal colic, less than 20% were operated on for pain and 7% spontaneously passed. Lower poles stones were significantly less likely to cause symptoms or pass spontaneously. Despite 3 stones causing silent hydronephrosissuggestive of obstruction, regular followup imaging facilitated interventions t
Complications
- Common complications of nephrolithiasis include:
Prognosis
- Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [#]%.
- Depending on the extent of the [tumor/disease progression/etc.] at the time of diagnosis, the prognosis may vary. However, the prognosis is generally regarded as poor/good/excellent.
- The presence of [characteristic of disease] is associated with a particularly [good/poor] prognosis among patients with [disease/malignancy].
- [Subtype of disease/malignancy] is associated with the most favorable prognosis.
- The prognosis varies with the [characteristic] of tumor; [subtype of disease/malignancy] have the most favorable prognosis.
References
- ↑ Dropkin BM, Moses RA, Sharma D, Pais VM (April 2015). "The natural history of nonobstructing asymptomatic renal stones managed with active surveillance". J. Urol. 193 (4): 1265–9. doi:10.1016/j.juro.2014.11.056. PMID 25463995.
- ↑ Worcester EM, Coe FL (June 2008). "Nephrolithiasis". Prim. Care. 35 (2): 369–91, vii. doi:10.1016/j.pop.2008.01.005. PMC 2518455. PMID 18486720.
- ↑ Madore F, Stampfer MJ, Willett WC, Speizer FE, Curhan GC (November 1998). "Nephrolithiasis and risk of hypertension in women". Am. J. Kidney Dis. 32 (5): 802–7. PMID 9820450.
- ↑ Ferraro PM, Taylor EN, Eisner BH, Gambaro G, Rimm EB, Mukamal KJ, Curhan GC (July 2013). "History of kidney stones and the risk of coronary heart disease". JAMA. 310 (4): 408–15. doi:10.1001/jama.2013.8780. PMC 4019927. PMID 23917291.